Virtus ETF Advisers’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,577
| Closed | -$63.8K | – | 463 |
|
|
2024
Q4 | $63.8K | Sell |
2,577
-885
| -26% | -$21.9K | 0.03% | 429 |
|
|
2024
Q3 | $98.7K | Buy |
3,462
+59
| +2% | +$1.68K | 0.05% | 379 |
|
|
2024
Q2 | $89.8K | Buy |
3,403
+1,372
| +68% | +$36.2K | 0.04% | 358 |
|
|
2024
Q1 | $65.6K | Sell |
2,031
-143
| -7% | -$4.62K | 0.03% | 412 |
|
|
2023
Q4 | $91.6K | Sell |
2,174
-2,473
| -53% | -$104K | 0.06% | 400 |
|
|
2023
Q3 | $178K | Sell |
4,647
-460
| -9% | -$17.7K | 0.11% | 283 |
|
|
2023
Q2 | $96.9K | Sell |
5,107
-1,594
| -24% | -$30.2K | 0.06% | 399 |
|
|
2023
Q1 | $104K | Sell |
6,701
-2,575
| -28% | -$39.9K | 0.06% | 334 |
|
|
2022
Q4 | $165K | Sell |
9,276
-21,091
| -69% | -$374K | 0.09% | 327 |
|
|
2022
Q3 | $169K | Buy |
30,367
+221
| +0.7% | +$1.23K | 0.07% | 335 |
|
|
2022
Q2 | $118K | Buy |
30,146
+8,984
| +42% | +$35.2K | 0.04% | 389 |
|
|
2022
Q1 | $117K | Sell |
21,162
-1,273
| -6% | -$7.04K | 0.05% | 272 |
|
|
2021
Q4 | $191K | Buy |
22,435
+2,641
| +13% | +$22.5K | 0.07% | 226 |
|
|
2021
Q3 | $172K | Sell |
19,794
-1,033
| -5% | -$8.98K | 0.08% | 305 |
|
|
2021
Q2 | $220K | Buy |
20,827
+14,684
| +239% | +$155K | 0.09% | 275 |
|
|
2021
Q1 | $99K | Buy |
6,143
+115
| +2% | +$1.85K | 0.04% | 351 |
|
|
2020
Q4 | $278K | Buy |
+6,028
| New | +$278K | 0.12% | 250 |
|